Full text is available at the source.
Abstract
Low-MW konjac glucomannan (KGM2) significantly altered fecal microflora during antibiotic treatment.
- KGM2 increased the relative abundance of beneficial bacteria (Bifidobacteriaceae) in the presence of antibiotics.
- KGM2 decreased the proportion of harmful bacteria (Enterobacteriaceae) when antibiotics were administered.
- Both native KGM and acid-treated KGM mitigated the negative effects of antibiotics on short chain fatty acid production.
- The study indicates that KGM may influence gut microbiota composition in the context of antibiotic disturbance.
Simplified